| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +2,100 | 0.32% | $25.30 | +$53,140 |
| Sells | 8 | -648,981 | 100% | $37.73 | -$24,489,054 |
| Net | -7 | -646,881 | -99% | -$24,435,914 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| James P. Mackin | President & CEO | $38,374,537 | -$9,172,807 | -19% | 02 Mar 2026 |
| John E. Davis | Chief Commercial Officer | $7,852,978 | -$2,466,395 | -24% | 02 Mar 2026 |
| Jean F Holloway | SVP, General Counsel | $7,659,924 | -$4,421,186 | -37% | 02 Mar 2026 |
| Lance A. Berry | EVP, COO, CFO & Treasurer | $6,702,611 | -$665,966 | -9% | 02 Mar 2026 |
| David Ashley Lee | Executive VP, COO & CFO | $6,655,986 | 01 Mar 2023 | ||
| Amy Horton | VP, Chief Accounting Officer | $5,920,071 | -$1,145,262 | -16% | 02 Mar 2026 |
| Daniel J. Bevevino | Director | $3,577,454 | 22 May 2025 | ||
| Thomas F. Ackerman | Director | $3,573,520 | 22 May 2025 | ||
| Jon W. Salveson | Director | $3,095,385 | 22 May 2025 | ||
| Ronald D McCall | Director | $2,191,824 | 25 Aug 2021 | ||
| Harvey Morgan | Director | $1,747,980 | 30 Aug 2021 | ||
| James Bullock | Director | $1,636,544 | 22 May 2025 | ||
| Marshall Stanton | SVP, Clinical & MD Affair | $1,496,286 | -$5,622,096 | -79% | 02 Mar 2026 |
| Jeffrey H. Burbank | Director | $1,282,496 | 22 May 2025 | ||
| Elizabeth A. Hoff | Director | $1,226,169 | -$189,412 | -13% | 18 Nov 2025 |
| Marna Borgstrom | Director | $1,170,257 | 22 May 2025 | ||
| Anthony B. Semedo | Director | $1,121,341 | -$20,887 | -1.8% | 23 May 2025 |
| Andrew M. Green | VP Regulatory | $1,005,090 | 04 Dec 2024 | ||
| Rochelle Maney | VP, Quality | $871,883 | 01 Mar 2024 | ||
| Matthew A. Getz | VP, Human Resources | $863,527 | 16 Aug 2024 | ||
| Dennis Maier | SVP, Operations | $625,032 | 06 Jun 2023 | ||
| Florian Tyrs | VP, Global Operations | $586,120 | 27 Feb 2024 | ||
| Franz Peter Barthold | VP, Research & Development | $585,288 | 08 Nov 2022 | ||
| Robert Thomson | VP Research & Development | $250,735 | 23 Feb 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|